공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 비뇨기 기기 시장 : 예측(2021-2026년)

Global Urology Devices Market - Forecasts from 2021 to 2026

리서치사 Knowledge Sourcing Intelligence
발행일 2021년 09월 상품 코드 1023167
페이지 정보 영문 115 Pages
US $ 3,950 ₩ 4,730,000 PDF (Single User License)
US $ 4,550 ₩ 5,448,000 PDF (Multiple User License)
US $ 6,950 ₩ 8,322,000 PDF (Enterprise License)

세계의 비뇨기 기기 시장 : 예측(2021-2026년) Global Urology Devices Market - Forecasts from 2021 to 2026
발행일 : 2021년 09월 페이지 정보 : 영문 115 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 비뇨기 기기 시장 규모는 2019년 282억 1,300만 달러에서 2026년에는 526억 8,400만 달러에 달하고, 예측기간 중 9.33%의 연평균 성장률로 성장할 것으로 예상됩니다.

비뇨기과 수술에서 발생하는 패턴으로는 신중한 개복 수술과 비교해 자상이 적고, 회복이 빠르고, 그리고 의료기관에서의 체재 기간이 짧은 등의 이점이 있기 때문에 눈에 띄지 않는 기기를 이용하는 경향이 있습니다. 이 시장의 현재 패턴은 레이저나 자동 지원 기기와 같은 최첨단 비뇨기 기기의 진보와 이용에 의해 수술 복잡성을 상당히 경감하고, 더 주목할 만한 정확함과 정밀도, 매우 난해하고 신중한 목적지 표명, 그리고 신속한 회복 등의 우수한 결과를 얻을 수 있습니다.

비뇨기 기기 시장의 발전을 촉진하는 주요 요인의 하나는 최소한의 번거로움을 제공하는 시스템에 대한 관심 상승입니다. 장기적으로 보면 과실에 의한 번거로움이 없는 의료 시술(MIS)은 혁신적인 진보를 이루고 있으며, 이것은 작업실에서 행해지는 비뇨기과 전략 방법의 전망에 변화를 가져왔습니다. 상처가 눈에 띄지 않는 주의 깊은 기기는 흉터가 적고, 회복이 빠르고, 더 한정적인 구급 진료소에서는 한정된 혈액 불운이나 손상을 막고, 오염 위험성이 낮고, 일반적인 의료비가 적어도 되는 등의 이점이 있습니다.

비뇨기과 분야에서 MIS는 비뇨기과 질환의 결론, 치료 및 관리를 위해 요로 및 관련 기관에 도달하기 위한 첨단 기계, 내시경 및 복강경을 포함합니다. 비뇨기과의가 가장 일반적으로 사용하고 있는 자동화된 프레임워크는 Intuitive Surgical(미국)의 Da Vinci 기계 의료 시술 프레임워크입니다. 이 시스템은 외과의가 기계화된 암에 장착된 기구를 제어하는 외과용 콘솔을 사용하고 있기 때문에 시장에 끊임없는 혁신이 존재하는 것을 나타내고 있으며, 비뇨기 기기 시장도 더욱 지지할 것으로 기대됩니다.

세계의 비뇨기 기기(Urology Devices) 시장에 대해 조사했으며, 시장의 기본 구조와 주요 성장 촉진·억제요인, 전체적인 시장 규모 동향 전망, 기기별·혈관 종류별·최종사용자별·지역별 상세 동향, 경쟁 상황 , 주요 기업 개요 등을 제공합니다.


제1장 서론

  • 시장 정의
  • 시장 세분화

제2장 조사 방법

  • 조사 데이터
  • 가정

제3장 주요 요약

  • 조사 하이라이트

제4장 시장 역학

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • Porter's Five Forces 분석
    • 공급 기업의 협상력
    • 구매자의 협상력
    • 신규 참여업체의 위협
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계
  • 기능 밸류체인 분석

제5장 비뇨기 기기 시장 분석 : 기기별

  • 서론
  • 투석용 기기
  • 내시경 기기
  • 레이저 및 쇄석술 기기
  • ENDO 비전 기기
  • 기타

제6장 비뇨기 기기 시장 분석 : 혈관 종류별

  • 서론
  • 전립선암
  • 방광암
  • 신장결석
  • 전립선 비대증
  • 기타

제7장 비뇨기 기기 시장 분석 : 최종사용자별

  • 서론
  • 병원 및 클리닉
  • 외래 진료 센터
  • 전문 클리닉

제8장 비뇨기 기기 시장 분석 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 남미
    • 브라질
    • 아르헨티나
    • 기타
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 기타
  • 중동 및 아프리카
    • 이스라엘
    • 사우디아라비아
    • 기타
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 호주
    • 한국
    • 대만
    • 태국
    • 인도네시아
    • 기타

제9장 경쟁 환경과 분석

  • 주요 기업과 전략 분석
  • 신흥 기업과 시장 수익성
  • 기업 인수합병(M&A)·계약·사업 협력
  • 벤더 각사의 경쟁력 매트릭스

제10장 기업 개요

  • STERIS Corporation
  • Integer Holdings Corporation
  • Olympus Corporation
  • Siemens Medical Solutions
  • Boston Scientific Corporation
  • Surgical Holdings
  • Medtronic
  • Dornier MedTech
  • Stryker
  • Cook Medical
KSM 21.09.10

The global urology devices market is expected to grow at a compound annual growth rate of 9.33% over the forecast period to reach a market size of US$52.684 billion in 2026 from US$28.213 billion in 2019. There is an emerging pattern for urological surgeries that utilize minimally intrusive instruments for reasons such as lesser cuts, a faster recovery rate, and fewer hospital stays compared to open surgical procedures. The urology devices market is currently experiencing cutting-edge advancements in urology medical devices, including laser and automated assisted devices, which help to make surgery significantly less demanding while presenting better outcomes such as higher exactness, deeper and more precise measurements, and a fast recovery.

One of the major drivers of the urology devices market's development must be an increasing demand for minimally intrusive devices. Negligibly intrusive medical procedures (MIS) have undergone an exceptional evolution as far as advances in technology go, which have greatly changed the way urological strategies in operating rooms are acted upon. A negligibly intrusive care device can provide a variety of benefits, including less scarring, quicker recovery, a shorter stay in the emergency room, diminished blood loss and injury, and a reduced risk of contamination. A laparoscopic, endoscopic, and robotic approach to the bladder lot and its surrounding organs is a key component of MIS in urology, which is used in the diagnosis, treatment, and monitoring of urological conditions. By far, the most regularly utilized automated platform among urologists is the da Vinci mechanical surgical system by Intuitive Surgical (US). By using a console in the operating room, a surgeon can control instruments attached to mechanized arms, which indicates that constant innovation is present in the market, adding to its growth prospects. The market is also witnessing various strategic actions being undertaken by companies in order to further increase their market share in response to the rising demand for urology devices. Medi-Tate, an Israeli medical device manufacturer owned by Olympus Corporation, was acquired by the Japanese company in May 2021. According to Olympus Corporation, the acquisition is a strategic move to expand its BPH product portfolio.

Growth Factors

Rising elderly population

Increasing population over the age of 65 will also drive the urology device market growth. Data from the United Nations (UN) 2019 estimates for the World Population Prospects show that the world population will increase by two billion people in the next 30 years, from the current 7.7 billion people to 9.7 billion by 2050, and the world's aging population will increase simultaneously. A decline in fertility rates and longer lives has led to an increase in the number of people aged 65 years and above and a decline in the number of children under five worldwide, as explained by the UN. A further increase in the number of over-65s will take place by 2050; they will be one in six (16%), compared to one out of eleven (9%) in 2019. Therefore, a growing geriatric population will result in an increased demand for urology devices, considering the increased prevalence of kidney disease among them.


Huge capital investment

Market players are engaged in intense competition. Just large companies are capable of purchasing high-capital projects as well as assembling and carrying out significant R&D. New entrants will have difficulty breaking into this market. The serious level of market saturation acts as a major barrier to entry for new players and is consequently relied upon to restrict ventures and consequently hinder the growth rate of this market. New players will likewise be repelled by the demand for large amounts of capital, a large cost of R&D, and significant labor costs.

COVID - 19 Impact

COVID-19 often results in acute respiratory distress in patients and may cause acute kidney injury, which is then followed by kidney failure. About 10% to 50% of COVID-19 patients who receive intensive care develop kidney failure and undergo dialysis, according to a study conducted by the American Society of Nephrology. Dialysis procedures will likely increase as a result of the growing number of patients infected with COVID-19 around the world. Furthermore, as a result of COVID 19 contamination, patients prefer to be treated at home. The result has been an increase in the use of urology equipment in homes. So, the global market for urology devices is experiencing demand from various end-user segments. In other words, it's possible that the COVID 19 pandemic has contributed positively to the growth of the global market for urology devices.

Competitive Insights

There has been an increased demand for urology devices, which has led to the entry of new players such as Stryker on the market. As these new players enter a market already home to traditional pharma behemoths like Olympus Corporation and STERIS Corporation, innovation is expected to continue to flourish in the urology devices market. Additionally, in order to broaden their client base and grow their share of the market in the future, major players have been taking various strategic steps such as forming partnerships and developing novel solutions that offer comfort to patients, thus ensuring the market remains competitive and is constantly evolving.


By Devices

  • Dialysis Devices
  • Endoscopic Devices
  • Lasers & Lithotripsy Devices
  • Endo vision Devices
  • Others

By Vessel Type

  • Prostate Cancer
  • Bladder Cancer
  • Kidney Stones
  • Benign Prostatic Hyperplasia
  • Others

By End-Users

  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Specialty Clinics

By Geography

  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Others
  • Middle East and Africa
    • Israel
    • Saudi Arabia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Function
  • 4.4. Function Value Chain Analysis

5. Urology Devices Market Analysis, By Devices

  • 5.1. Introduction
  • 5.2. Dialysis Devices
  • 5.3. Endoscopic Devices
  • 5.4. Lasers & Lithotripsy Devices
  • 5.5. Endo vision Devices
  • 5.6. Others

6. Urology Devices Market Analysis, By Vessel Type

  • 6.1. Introduction
  • 6.2. Prostate Cancer
  • 6.3. Bladder Cancer
  • 6.4. Kidney Stones
  • 6.5. Benign Prostatic Hyperplasia
  • 6.6. Others

7. Urology Devices Market Analysis, By End-Users

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Care Centers
  • 7.4. Specialty Clinics

8. Global Urology Devices Market Analysis, By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. UK
    • 8.4.2. Germany
    • 8.4.3. Italy
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. The Middle East and Africa
    • 8.5.1. Israel
    • 8.5.2. Saudi Arabia
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. Japan
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. South Korea
    • 8.6.6. Taiwan
    • 8.6.7. Thailand
    • 8.6.8. Indonesia
    • 8.6.9. Others

9. Competitive Environment and Analysis

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. Company Profiles

  • 10.1. STERIS Corporation
  • 10.2. Integer Holdings Corporation
  • 10.3. Olympus Corporation
  • 10.4. Siemens Medical Solutions
  • 10.5. Boston Scientific Corporation
  • 10.6. Surgical Holdings
  • 10.7. Medtronic
  • 10.8. Dornier MedTech
  • 10.9. Stryker
  • 10.10. Cook Medical
Back to Top
전화 문의